Criteria, prevalence, and phenotypes of polycystic ovary syndrome
- PMID: 27233760
- DOI: 10.1016/j.fertnstert.2016.05.003
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a highly prevalent disorder effecting reproductive-aged women worldwide. This article addresses the evolution of the criteria used to diagnosis PCOS; reviews recent advances in the phenotypic approach, specifically in the context of the extended Rotterdam criteria; discusses limitations of the current criteria used to diagnosis, particularly when studying adolescents and women in the peri- and postmenopause; and describes significant strides made in understanding the epidemiology of PCOS. This review recognizes that although there is a high prevalence of PCOS, there is increased variability when using Rotterdam 2003 criteria, owing to limitations in population sampling and approaches used to define PCOS phenotypes. Last, we discuss the distribution of PCOS phenotypes, their morbidity, and the role that referral bias plays in the epidemiology of this syndrome.
Keywords: Phenotypes; polycystic ovary syndrome; prevalence; referral bias.
Copyright © 2016 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.Fertil Steril. 2016 Nov;106(6):1510-1520.e2. doi: 10.1016/j.fertnstert.2016.07.1121. Epub 2016 Aug 13. Fertil Steril. 2016. PMID: 27530062 Review.
-
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22. Hum Reprod. 2016. PMID: 27664216 Review.
-
Criteria, phenotypes and prevalence of polycystic ovary syndrome.Minerva Ginecol. 2019 Jun;71(3):211-223. doi: 10.23736/S0026-4784.19.04404-6. Minerva Ginecol. 2019. PMID: 31089072 Review.
-
The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.Hum Reprod. 2014 Apr;29(4):791-801. doi: 10.1093/humrep/det469. Epub 2014 Jan 16. Hum Reprod. 2014. PMID: 24435776
-
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Hum Reprod. 2012 Oct;27(10):3067-73. doi: 10.1093/humrep/des232. Epub 2012 Jul 9. Hum Reprod. 2012. PMID: 22777527
Cited by
-
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment.Medicina (Kaunas). 2024 Oct 10;60(10):1656. doi: 10.3390/medicina60101656. Medicina (Kaunas). 2024. PMID: 39459443 Free PMC article. Review.
-
Female sexual function in different phenotypes of polycystic ovarian syndrome: a comparative cross-sectional study.Sci Rep. 2022 Nov 11;12(1):19317. doi: 10.1038/s41598-022-24026-7. Sci Rep. 2022. PMID: 36369524 Free PMC article.
-
Effect of Vitamin D Status on Vascular Function of the Aorta in a Rat Model of PCOS.Oxid Med Cell Longev. 2021 Mar 18;2021:8865979. doi: 10.1155/2021/8865979. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33791074 Free PMC article.
-
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review.Nutrients. 2024 Oct 6;16(19):3397. doi: 10.3390/nu16193397. Nutrients. 2024. PMID: 39408364 Free PMC article. Review.
-
Roles of estrogen and its receptors in polycystic ovary syndrome.Front Cell Dev Biol. 2024 Jun 19;12:1395331. doi: 10.3389/fcell.2024.1395331. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38961865 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
